Enhance your patient care with WoundQ™, designed to streamline and accelerate the Benefit Verification Process. WoundQ empowers you to optimize operations and provide faster, more
efficient services.
Forget paper faxes and the complications that follow. Instead, easily submit Benefit Verification for Kerecis through WoundQ, ensuring accurate data submission.
Insurance and patient information is automatically provided from WoundQ.
Real time tracking and monitoring of the Benefit Verification approval process provides instant visibility into results.
From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.